Neuronetics Stock-Based Compensation Growth & History (STIM)
Neuronetics's stock-based compensation was $6.8M for fiscal 2025.
View full Neuronetics company overviewNeuronetics annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $6.8M | $1.2M | +22.24% |
| 2024 | 2024-12-31 | $5.6M | −$1.7M | −23.46% |
| 2023 | 2023-12-31 | $7.3M | −$1.4M | −16.32% |
| 2022 | 2022-12-31 | $8.7M | $877,000 | +11.14% |
| 2021 | 2021-12-31 | $7.9M | $3.5M | +78.68% |
| 2020 | 2020-12-31 | $4.4M | $970,000 | +28.25% |
| 2019 | 2019-12-31 | $3.4M | $1.7M | +97.02% |
| 2018 | 2018-12-31 | $1.7M | $1.2M | +251.41% |
| 2017 | 2017-12-31 | $496,000 | $335,000 | +208.07% |
| 2016 | 2016-12-31 | $161,000 | — | — |
Neuronetics quarterly stock-based compensation
| Fiscal quarter | Period ended | Stock-based compensation | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $688,000 | −$1.1M | −62.07% |
| Q1 2026 | 2026-03-31 | $1.7M | $233,000 | +16.14% |
| Q4 2025 | 2025-12-31 | $2.2M | $899,000 | +70.12% |
| Q3 2025 | 2025-09-30 | $1.4M | −$10,000 | −0.70% |
| Q2 2025 | 2025-06-30 | $1.8M | $251,000 | +16.06% |
| Q1 2025 | 2025-03-31 | $1.4M | $106,000 | +7.92% |
| Q4 2024 | 2024-12-31 | $1.3M | −$344,000 | −21.16% |
| Q3 2024 | 2024-09-30 | $1.4M | −$436,000 | −23.50% |
| Q2 2024 | 2024-06-30 | $1.6M | −$470,000 | −23.12% |
| Q1 2024 | 2024-03-31 | $1.3M | −$467,000 | −25.87% |
| Q4 2023 | 2023-12-31 | $1.6M | −$487,000 | −23.05% |
| Q3 2023 | 2023-09-30 | $1.9M | −$323,000 | −14.83% |
| Q2 2023 | 2023-06-30 | $2.0M | −$170,000 | −7.72% |
| Q1 2023 | 2023-03-31 | $1.8M | −$447,000 | −19.85% |
| Q4 2022 | 2022-12-31 | $2.1M | $410,000 | +24.08% |
| Q3 2022 | 2022-09-30 | $2.2M | $217,000 | +11.07% |
| Q2 2022 | 2022-06-30 | $2.2M | $194,000 | +9.66% |
| Q1 2022 | 2022-03-31 | $2.3M | $56,000 | +2.55% |
| Q4 2021 | 2021-12-31 | $1.7M | $187,000 | +12.34% |
| Q3 2021 | 2021-09-30 | $2.0M | $915,000 | +87.48% |
| Q2 2021 | 2021-06-30 | $2.0M | $1.4M | +210.99% |
| Q1 2021 | 2021-03-31 | $2.2M | $1.0M | +83.61% |
| Q4 2020 | 2020-12-31 | $1.5M | $540,000 | +55.33% |
| Q3 2020 | 2020-09-30 | $1.0M | $111,000 | +11.87% |
| Q2 2020 | 2020-06-30 | $646,000 | −$376,000 | −36.79% |
| Q1 2020 | 2020-03-31 | $1.2M | $695,000 | +138.72% |
| Q4 2019 | 2019-12-31 | $976,000 | $597,000 | +157.52% |
| Q3 2019 | 2019-09-30 | $935,000 | −$93,000 | −9.05% |
| Q2 2019 | 2019-06-30 | $1.0M | $830,000 | +432.29% |
| Q1 2019 | 2019-03-31 | $501,000 | $357,000 | +247.92% |
| Q4 2018 | 2018-12-31 | $379,000 | — | — |
| Q3 2018 | 2018-09-30 | $1.0M | $931,000 | +959.79% |
| Q2 2018 | 2018-06-30 | $192,000 | $36,000 | +23.08% |
| Q1 2018 | 2018-03-31 | $144,000 | — | — |
| Q3 2017 | 2017-09-30 | $97,000 | — | — |
| Q2 2017 | 2017-06-30 | $156,000 | — | — |
Neuronetics stock-based compensation trends
Over the last five fiscal years, Neuronetics's stock-based compensation increased from $4.4M to $6.8M, a change of $2.4M. The latest reported quarter, Q2 2026, shows $688,000.
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
SEC-reported stock-based compensation
TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Neuronetics source filings ↗